p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: Association with cancer progression and prognosis

Hepatology

Volumn 31, Issue 5, 2000, Pages 1068-1072

  Hui, A I Min ^a   Xin, Li ^a   Shi, Y A Zhou ^a   Torzilli, Guido ^a   Takayama, Tadatoshi ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27;

ADENOMA; ADENOMYOMATOSIS; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

EID: 17544366706     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.6127     Document Type: Article

References (14)

1. Kamel D, Paakko P, Nuorva K, Vahakangas K, Soini Y. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 1993;170:67-72.
2. Watanabe M, Asaka M, Tanaka J, Kurosaka M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107:1147-1153.
3. Wee A, The M, Raju GC. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions. J Clin Pathol 1994;47:453-456.
4. Imai M, Hoshi T, Ogawa K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 1994;73:2727-2733.
5. Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, Saitoh Y. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 1996;38:426-429.
6. Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimori T, Maeda S, Saitoh Y. p53 protein expression and prognosis in gall bladder carcinoma and premalignant lesions. Hepato-Gastroenterol 1996;43:521-526.
7. Peter M, Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994;79:181-184.
8. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinase. Genes Dev 1995;9:1149-1163.
9. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor- and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
10. Kip1, a cyclin-Cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78:59-66.
11. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78:67-74.
12. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
13. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH, Seth P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997;57:5441-5445.
14. Durand B, Gao FB, Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 1997;16:306-317.